Fresh on the heels of the U.S. Food and Drug Administration's approval of the controversial Alzheimer's drug Aduhelm, the maker of a second medicine that works in similar fashion said Thursday it hopes to apply for approval ...
Jun 25, 2021
0
5
Two coronavirus strains first detected in California have been classified as "variants of concern" by the U.S. Centers for Disease Control and Prevention.
Mar 18, 2021
0
6
Eli Lilly & Co. presented highly anticipated details from a mid-stage study showing that its experimental drug modestly slowed Alzheimer's disease progression over about 18 months.
Mar 15, 2021
0
3
Jason Wallach has a vision. He sees Philadelphia becoming a center for psychedelic studies. From his laboratory at the University of the Sciences, Wallach is leading a network of national researchers delving into the mind-altering ...
Feb 17, 2021
0
10
New results extend hopes for drugs that supply antibodies to fight COVID-19, suggesting they can help keep patients out of the hospital and possibly prevent illness in some uninfected people.
Jan 26, 2021
0
24
When President Trump was diagnosed with COVID-19, one of the cutting-edge experimental therapies he received was a mixture of monoclonal antibodies. But now a vaccine may soon be available. So are other therapies necessary ...
Nov 16, 2020
0
3
(HealthDay)—In an alarming sign that the coronavirus pandemic is about to hammer the United States with unprecedented force, the country reported a record-shattering 140,000 new cases on Wednesday.
Nov 12, 2020
0
3
U.S. health officials have allowed emergency use of the first antibody drug to help the immune system fight COVID-19, an experimental approach against the virus that has killed more than 238,000 Americans.
Nov 10, 2020
0
4
Independent monitors have paused enrollment in a study testing the COVID-19 antiviral drug remdesivir plus an experimental antibody therapy being developed by Eli Lilly that's similar to a treatment President Donald Trump ...
Oct 14, 2020
0
5
Two US companies have applied for emergency approval for their lab-produced antibodies against COVID-19—and President Donald Trump has signaled his strong backing based on the fact he was treated with one of them.
Oct 8, 2020
0
4
